Literature DB >> 11822975

Heart rate variability and cardiovascular mortality.

Rollo P Villareal1, Brant C Liu, Ali Massumi.   

Abstract

The autonomic nervous system plays a major role in affecting the cardiac milieu and promoting malignant ventricular activity. The measurement of heart rate variability (HRV) is a noninvasive tool for assessing the status of the autonomic nervous system. A depressed HRV among post-myocardial infarction patients is a well-established risk factor for arrhythmic death. A reduced HRV has also been used to identify diabetic patients with autonomic neuropathy. This paper presents recent developments in the use of HRV, focusing on further refinement and validation of the use of both linear and nonlinear dynamics for sudden death prognostication, evaluation of the effect of specific pharmacologic agents on HRV, and assessment of HRV in health and in specific disease states that have been associated with an increased mortality risk.

Entities:  

Mesh:

Year:  2002        PMID: 11822975     DOI: 10.1007/s11883-002-0035-1

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  46 in total

1.  Beneficial effects of long-term treatment with enalapril on cardiac function and heart rate variability in patients with old myocardial infarction.

Authors:  T Ooie; T Saikawa; M Hara; T Takakura; Y Sato; T Sakata
Journal:  J Card Fail       Date:  1999-12       Impact factor: 5.712

2.  Heart rate dynamics at the onset of ventricular tachyarrhythmias as retrieved from implantable cardioverter-defibrillators in patients with coronary artery disease.

Authors:  E Pruvot; G Thonet; J M Vesin; G van-Melle; K Seidl; H Schmidinger; J Brachmann; W Jung; E Hoffmann; R Tavernier; M Block; A Podczeck; M Fromer
Journal:  Circulation       Date:  2000-05-23       Impact factor: 29.690

3.  Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery disease.

Authors:  A N Pehlivanidis; V G Athyros; D S Demitriadis; A A Papageorgiou; V J Bouloukos; A G Kontopoulos
Journal:  Atherosclerosis       Date:  2001-08       Impact factor: 5.162

4.  Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure.

Authors:  K M Yee; S D Pringle; A D Struthers
Journal:  J Am Coll Cardiol       Date:  2001-06-01       Impact factor: 24.094

5.  Decreased heart rate variability and its association with increased mortality after acute myocardial infarction.

Authors:  R E Kleiger; J P Miller; J T Bigger; A J Moss
Journal:  Am J Cardiol       Date:  1987-02-01       Impact factor: 2.778

6.  Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control.

Authors:  S Akselrod; D Gordon; F A Ubel; D C Shannon; A C Berger; R J Cohen
Journal:  Science       Date:  1981-07-10       Impact factor: 47.728

7.  Long-term beta-blocker therapy improves autonomic nervous regulation in advanced congestive heart failure: a longitudinal heart rate variability study.

Authors:  J L Lin; H L Chan; C C Du; I N Lin; C W Lai; K T Lin; C P Wu; Y Z Tseng; W P Lien
Journal:  Am Heart J       Date:  1999-04       Impact factor: 4.749

8.  Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy.

Authors:  L Fauchier; D Babuty; P Cosnay; J P Fauchier
Journal:  J Am Coll Cardiol       Date:  1999-04       Impact factor: 24.094

9.  Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction.

Authors:  E Vanoli; G M De Ferrari; M Stramba-Badiale; S S Hull; R D Foreman; P J Schwartz
Journal:  Circ Res       Date:  1991-05       Impact factor: 17.367

10.  Effect of quinapril or metoprolol on circadian sympathetic and parasympathetic modulation after acute myocardial infarction.

Authors:  A G Kontopoulos; V G Athyros; A A Papageorgiou; H Boudoulas
Journal:  Am J Cardiol       Date:  1999-11-15       Impact factor: 2.778

View more
  25 in total

Review 1.  Physiology and immunology of the cholinergic antiinflammatory pathway.

Authors:  Kevin J Tracey
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

Review 2.  Heart rate variability: a review.

Authors:  U Rajendra Acharya; K Paul Joseph; N Kannathal; Choo Min Lim; Jasjit S Suri
Journal:  Med Biol Eng Comput       Date:  2006-11-17       Impact factor: 2.602

3.  Exercise training improves heart rate variability in older patients with heart failure: a randomized, controlled, single-blinded trial.

Authors:  Khalil Murad; Peter H Brubaker; David M Fitzgerald; Timothy M Morgan; David C Goff; Elsayed Z Soliman; Joel D Eggebeen; Dalane W Kitzman
Journal:  Congest Heart Fail       Date:  2012-04-26

4.  The impact of 2 years of high-intensity exercise training on a model of integrated cardiovascular regulation.

Authors:  Michinari Hieda; Erin J Howden; Satyam Sarma; William Cornwell; Justin S Lawley; Takashi Tarumi; Dean Palmer; Mitchel Samels; Braden Everding; Sheryl Livingston; Qi Fu; Rong Zhang; Benjamin D Levine
Journal:  J Physiol       Date:  2018-11-22       Impact factor: 5.182

5.  [Impairment of cardiac autonomic nervous system and incidence of arrhythmias in severe hyperglycemia].

Authors:  Sven Süfke; Hasib Djonlagić; Thomas Kibbel
Journal:  Med Klin (Munich)       Date:  2011-01-16

6.  Chromogranin a and the autonomic system: decomposition of heart rate variability and rescue by its catestatin fragment.

Authors:  Nagendu B Dev; Jiaur R Gayen; Daniel T O'Connor; Sushil K Mahata
Journal:  Endocrinology       Date:  2010-04-21       Impact factor: 4.736

7.  Gene-trapped mouse embryonic stem cell-derived cardiac myocytes and human genetics implicate AKAP10 in heart rhythm regulation.

Authors:  Whittemore G Tingley; Ludmila Pawlikowska; Jonathan G Zaroff; Taeryn Kim; Trieu Nguyen; Stephen G Young; Karen Vranizan; Pui-Yan Kwok; Mary A Whooley; Bruce R Conklin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-07       Impact factor: 11.205

8.  Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice.

Authors:  Mark Veugelers; David Wilkes; Kimberly Burton; Deborah A McDermott; Yan Song; Marsha M Goldstein; Krista La Perle; Carl J Vaughan; Art O'Hagan; Kenneth R Bennett; Beat J Meyer; Eric Legius; Mervi Karttunen; Reijo Norio; Helena Kaariainen; Michael Lavyne; Jean-Philippe Neau; Gert Richter; Kaan Kirali; Alan Farnsworth; Karen Stapleton; Peter Morelli; Yoshinori Takanashi; John-Steven Bamforth; Franz Eitelberger; Irene Noszian; Waldimiro Manfroi; James Powers; Yoshihiko Mochizuki; Tsuneo Imai; Gary T C Ko; Deborah A Driscoll; Elizabeth Goldmuntz; Jay M Edelberg; Amanda Collins; Diana Eccles; Alan D Irvine; G Stanley McKnight; Craig T Basson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-15       Impact factor: 11.205

9.  Shift to an involvement of phosphatidylinositol 3-kinase in angiotensin II actions on nucleus tractus solitarii neurons of the spontaneously hypertensive rat.

Authors:  Chengwen Sun; Jasenka Zubcevic; Jaimie W Polson; Jeffrey T Potts; Carlos Diez-Freire; Qi Zhang; Julian F R Paton; Mohan K Raizada
Journal:  Circ Res       Date:  2009-10-22       Impact factor: 17.367

Review 10.  Active recovery from concussion.

Authors:  John J Leddy; Charles G Wilber; Barry S Willer
Journal:  Curr Opin Neurol       Date:  2018-12       Impact factor: 5.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.